Ligand Pharmaceuticals (LGND)
NASDAQ: LGND
· Real-Time Price · USD
150.89
-2.90 (-1.89%)
At close: Aug 15, 2025, 3:59 PM
151.08
0.13%
After-hours: Aug 15, 2025, 04:10 PM EDT
Ligand Pharmaceuticals Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 245.02M | 47.99M | 72.31M | 63.62M | 18.14M | 50.09M | 22.95M | 19.27M | 219.04M | 282.67M | 45.01K | 4.12M | 5.28M | 14.99M | 19.52M | 23.43M | 21.86M | 31.85M |
Short-Term Investments | n/a | 160.91M | 183.86M | 156.02M | 208.79M | 260.5M | 147.35M | 171.23M | 190.6M | 193.94M | 166.86K | 117.29M | 142.66M | 189.01M | 321.59M | 299.78M | 279.97M | 307.35M |
Long-Term Investments | 28.87M | 199.23M | 195.93M | 212.4M | 47.68M | 46.97M | 48.32M | 47.16M | n/a | n/a | 3M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 202.67M | 25.92M | 17.51M | 27.65M | 92.4M | 26.33M | 21.53M | 20.74M | 15.88M | 16.38M | 14.22M | 39.7M | 37.27M | 31.03M | 23.25M | 3.1M | 20.46M | 19.95M |
Receivables | 41.29M | 42.83M | 42.45M | 42.13M | 37.48M | 28.43M | 39.31M | 36M | 27.99M | 29.19M | 35.04M | 65.95M | 63.27M | 41.8M | 91.65M | 70.71M | 62.85M | 55.58M |
Inventory | 15.49M | 11.81M | 14.11M | 13.44M | 20.71M | 21.34M | 23.97M | 25.39M | 26.91M | 14.01M | 13.29M | 22.33M | 24.77M | 25.61M | 27.33M | 33M | 39.95M | 36.93M |
Other Current Assets | 51.15M | 42.97M | 16.9M | 30.87M | 25.23M | 7.31M | 2.66M | 2.1M | 2.77M | 2.33M | 2.27M | 10.75M | 7.8M | 4.66M | 4.67M | 5.16M | 6.27M | 5.71M |
Total Current Assets | 352.94M | 309.32M | 331.56M | 309.39M | 312.26M | 368.91M | 237.43M | 257.76M | 276.71M | 328.19M | 263.6M | 220.43M | 243.78M | 276.07M | 464.75M | 432.08M | 410.9M | 437.43M |
Property-Plant & Equipment | 11.62M | 10.49M | 24.81M | 25.19M | 25.46M | 24.38M | 9.46M | 9.8M | 15.15M | 15.61M | 15.01M | 46.55M | 39.74M | 31.4M | 32.75M | 48.45M | 23.88M | 25.56M |
Goodwill & Intangibles | 351.67M | 359.93M | 371.9M | 380.15M | 388.41M | 396.67M | 470.27M | 425.21M | 441.83M | 450.02M | 458.31M | 708.42M | 719.84M | 731.03M | 745.11M | 763.3M | 773.16M | 784.75M |
Total Long-Term Assets | 595.66M | 596.12M | 610.22M | 645.48M | 554.15M | 544.96M | 595.63M | 511.45M | 481.39M | 482.88M | 499.07M | 830.17M | 832.5M | 829.12M | 836.63M | 841.57M | 845.38M | 857.69M |
Total Assets | 948.6M | 905.43M | 941.77M | 954.87M | 866.4M | 913.87M | 833.06M | 769.21M | 758.11M | 811.08M | 762.67M | 1.05B | 1.08B | 1.11B | 1.3B | 1.27B | 1.26B | 1.3B |
Account Payables | 26.05M | 5.37M | 5.23M | 4.69M | 1.79M | 1.89M | 2.43M | 2.48M | 9.58M | 6.13M | 5.31M | 15.89M | 19.15M | 6.97M | 8.4M | 7.23M | 17.27M | 9.47M |
Deferred Revenue | 111K | 722K | 1.9M | 1.15M | 1.2M | 1.23M | 1.22M | 4.34M | 11.39M | 257K | 355K | 9.55M | 10.58M | 10.5M | 11M | 12.01M | 17.15M | 25.11M |
Short-Term Debt | 1.11M | n/a | n/a | n/a | 1.17M | n/a | 4.19M | 497K | 680K | 76.79M | 76.69M | 76.6M | 114.97M | 1.9M | n/a | 2.23M | 2.32M | 7.61M |
Other Current Liabilities | 37.16M | 28.88M | -3.2M | 15.73M | 10.55M | 10.65M | 8.04M | 3.31M | 2.11M | 13.31M | 9.54M | 14.88M | 12.14M | 9.04M | 19.45M | 8.04M | 9.75M | 42.66M |
Total Current Liabilities | 64.73M | 58.68M | 37.11M | 24.77M | 18.57M | 17.82M | 16.78M | 18.87M | 29.39M | 98.93M | 98.81M | 135.24M | 167.85M | 42.58M | 41.66M | 36.3M | 52.5M | 95.81M |
Long-Term Debt | 4.63M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 176.54M | 320.72M | 316.89M | 315.32M | 352.31M |
Other Long-Term Liabilities | 18.47M | 18.27M | 35.88M | 36.24M | 33.4M | 30.67M | 62.32M | 47.19M | 25.17M | 24.64M | 25.38M | 28.8M | 28.89M | 36.64M | 111.73M | 33.91M | 37.13M | 38.27M |
Total Long-Term Liabilities | 55.34M | 51.22M | 74.22M | 88.92M | 72.64M | 89.53M | 113.92M | 84.94M | 63.83M | 65.83M | 66.37M | 99.07M | 106.07M | 269.41M | 438.09M | 425.29M | 417.27M | 453.48M |
Total Liabilities | 120.08M | 109.9M | 111.33M | 113.69M | 91.21M | 107.35M | 130.71M | 103.81M | 93.21M | 164.76M | 165.18M | 234.31M | 273.92M | 311.99M | 479.75M | 461.59M | 469.77M | 549.28M |
Total Debt | 5.74M | 4.45M | 7.11M | 7.36M | 7.58M | 6.19M | 6.17M | 6.33M | 11.67M | 88.68M | 87.75M | 113.89M | 144.61M | 178.44M | 336.26M | 330.58M | 317.64M | 359.92M |
Common Stock | n/a | 20K | 20K | 19K | 19K | 18K | 18K | 18K | 17K | 17K | 17.00 | 17K | 17K | 17K | 17K | 17K | 17K | 17K |
Retained Earnings | n/a | 456.53M | 498.98M | 530.07M | 537.24M | 589.15M | 503.02M | 484.83M | 495.1M | 492.81M | 450.86K | 468.35M | 467.94M | 468.84M | 449.09M | 454.51M | 440.78M | 410.06M |
Comprehensive Income | n/a | -1.56M | -5.94M | 1.75M | -935K | -910K | -817K | -944K | -967K | -935K | -984 | -1.06M | -1.07M | -1.03M | -917K | -875K | -861K | -856K |
Shareholders Equity | 828.53M | 795.53M | 830.44M | 841.18M | 775.2M | 806.52M | 700.91M | 665.4M | 664.89M | 646.32M | 597.49M | 816.3M | 802.37M | 793.19M | 821.63M | 812.07M | 786.52M | 745.84M |
Total Investments | 28.87M | 360.14M | 379.79M | 368.43M | 256.48M | 307.47M | 195.68M | 204.32M | 190.6M | 193.94M | 166.86K | 117.29M | 142.66M | 189.01M | 321.59M | 299.78M | 279.97M | 307.35M |